The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto Neuroscience, Inc. ("Alto Neuroscience" or "the Company") (NYSE:ANRO) for violations of the securities laws. The investigation focuses on whether the Company issued […]

NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation

Lost Money on FTAI Aviation Ltd. (FTAI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=124405&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia Therapeutics, Inc. ("Intellia Therapeutics, Inc.") (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release on January 9, 2025, "announc[ing] its strategic priorities and key anticipated 2025 milestones".

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit – KYTX

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=124399&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into MSCI Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MSCI Inc. ("MSCI" or "the Company") (NYSE:MSCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

HelloFresh SE Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HelloFresh SE ("HelloFresh" or "the Company") (OTC PINK:HLFFF) for violations of the securities laws. The investigation focuses on whether the Company issued false

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. – XBIT

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XBiotech Inc.("XBiotech" or the "Company") (NASDAQ:XBIT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns Micron and certain of its officers and/or directors have engaged in

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Transocean Ltd. (RIG) Shareholders

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=124404&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

RVNC LAWSUIT ALERT: Levi & Korsinsky Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124401&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top